Oracle (NYSE:ORCL) Stock Price Down 3.2% - Should You Sell?

Key Points

• Oracle shares fell 3.2% to about $144.44, below the 200-day moving average of $160.41, despite recent quarterly results that beat analyst expectations and showed 29.6% year-over-year revenue growth.
• Oracle’s AI, healthcare and cloud offerings continue to expand, supported by new product launches, customer adoption and infrastructure partnerships. However, heavy data-center spending, negative free cash flow and reported layoffs remain key execution and financing concerns.
• Wall Street remains broadly positive, with a “Moderate Buy” consensus rating and an average price target of $252.58, while Oracle offers a $0.50 quarterly dividend, equivalent to a 1.4% yield.

Oracle Corporation (NYSE:ORCL - Get Free Report) was down 3.2% during trading on Wednesday . The stock traded as low as $144.23 and last traded at $144.4390. 22,069,224 shares changed hands during trading, a decline of 25% from the average daily volume of 29,318,178 shares. The stock had previously closed at $149.20.

Key Headlines Impacting Oracle

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Expanded AI and healthcare offerings: Oracle introduced an AI-enabled Oncology EHR and new AI capabilities for revenue-cycle management, while its Life Sciences Data Intelligence platform is being expanded with real-world data, analytics and domain-specific AI. These launches could support long-term growth in healthcare and pharmaceutical software. Oracle to Advance Cancer Care with New Oncology EHR
• Positive Sentiment: Research and customer adoption provide commercial validation: The Buck Institute is using Oracle’s health data and analytics to research age-related disease, while U.K. venue Co-op Live is deploying Oracle Simphony Cloud POS and NetSuite. Such announcements reinforce Oracle’s push to expand cloud applications beyond its traditional database business. Oracle and Buck Institute for Research on Aging
• Positive Sentiment: AI infrastructure ecosystem continues to broaden: FlashGrid added support for Oracle AI Database 26ai on native infrastructure-as-a-service clouds, potentially improving adoption of Oracle’s AI-native database platform. Oracle’s reported cloud growth and large backlog also continue to attract bullish analyst commentary. FlashGrid adds support for Oracle AI Database 26ai deployments
• Neutral Sentiment: Wipro partnership targets drug-safety services: Oracle and Wipro will offer managed cloud-based pharmacovigilance services using Oracle Life Sciences Argus. The deal expands Oracle’s addressable market, although its near-term revenue impact is not disclosed. Oracle Partners with Wipro to Strengthen End-to-End Pharmacovigilance Services
• Negative Sentiment: Funding and cash-flow concerns remain the main overhang: Reports highlight persistent debt issuance and higher borrowing costs tied to Oracle’s data-center expansion, alongside negative free cash flow. Investors are questioning whether AI demand will generate adequate returns to justify the required capital investment. Oracle Edged Higher While AI Borrowers Pay 37 Extra Basis Points
• Negative Sentiment: Layoffs add execution concerns: More than 500 U.S. cloud-infrastructure employees were reportedly laid off, including engineers, developers, managers and data-center support staff. The cuts may improve efficiency, but they also raise questions about capacity and execution while Oracle is aggressively building its AI cloud business. Revealed: Some of the Oracle cloud roles hit hardest in layoffs

Analyst Upgrades and Downgrades

ORCL has been the topic of a number of research reports. Sanford C. Bernstein reaffirmed an "outperform" rating on shares of Oracle in a research note on Wednesday, September 2nd. UBS Group boosted their price target on Oracle from $245.00 to $250.00 and gave the company a "buy" rating in a report on Friday, September 11th. Barclays increased their target price on shares of Oracle from $250.00 to $252.00 and gave the stock an "overweight" rating in a report on Friday, September 11th. BTIG Research restated a "buy" rating and set a $400.00 price objective on shares of Oracle in a research report on Friday, June 5th. Finally, Stephens reiterated an "equal weight" rating and issued a $175.00 price target on shares of Oracle in a research note on Friday, September 11th. Two equities research analysts have rated the stock with a Strong Buy rating, thirty have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $252.58.

Oracle Price Performance

The firm's 50-day moving average price is $142.15 and its 200-day moving average price is $160.41. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 1.89. The stock has a market capitalization of $436.75 billion, a PE ratio of 22.64, a PEG ratio of 1.06 and a beta of 1.74.

Oracle (NYSE:ORCL - Get Free Report) last posted its quarterly earnings data on Thursday, September 10th. The enterprise software provider reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.18. Oracle had a return on equity of 48.85% and a net margin of 26.36%.The business had revenue of $19.34 billion during the quarter, compared to analyst estimates of $19.13 billion. During the same period last year, the company earned $1.47 EPS. The company's revenue for the quarter was up 29.6% on a year-over-year basis. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. On average, equities analysts forecast that Oracle Corporation will post 6.67 EPS for the current fiscal year.

Oracle Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 23rd. Stockholders of record on Friday, October 9th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, October 9th. Oracle's payout ratio is presently 31.35%.

Insider Activity at Oracle

In other news, CEO Michael Sicilia sold 10,882 shares of the firm's stock in a transaction dated Wednesday, September 16th. The shares were sold at an average price of $139.94, for a total value of $1,522,827.08. Following the sale, the chief executive officer directly owned 149,084 shares in the company, valued at approximately $20,862,814.96. This trade represents a 6.80% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 40.90% of the company's stock.

Institutional Investors Weigh In On Oracle

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Sherman Asset Management Inc. raised its stake in shares of Oracle by 5.5% in the 1st quarter. Sherman Asset Management Inc. now owns 1,054 shares of the enterprise software provider's stock valued at $155,000 after acquiring an additional 55 shares during the period. Southern Capital Advisors LLC increased its holdings in Oracle by 1.3% in the 1st quarter. Southern Capital Advisors LLC now owns 4,446 shares of the enterprise software provider's stock valued at $654,000 after purchasing an additional 57 shares during the last quarter. Global Financial Private Client LLC raised its position in Oracle by 0.8% in the first quarter. Global Financial Private Client LLC now owns 7,836 shares of the enterprise software provider's stock valued at $1,153,000 after purchasing an additional 59 shares during the period. Key Financial Inc lifted its stake in Oracle by 0.4% during the first quarter. Key Financial Inc now owns 14,203 shares of the enterprise software provider's stock worth $2,089,000 after purchasing an additional 62 shares in the last quarter. Finally, Gould Asset Management LLC CA boosted its position in shares of Oracle by 2.0% during the first quarter. Gould Asset Management LLC CA now owns 3,172 shares of the enterprise software provider's stock worth $467,000 after buying an additional 62 shares during the period. 42.44% of the stock is currently owned by hedge funds and other institutional investors.

Oracle Company Profile

Oracle Corporation is a global enterprise technology company that develops and provides database software, cloud infrastructure, business applications and related technology services. Its offerings help organizations manage data, run applications, support business operations and build technology environments across on-premises, hybrid and cloud-based settings.

The company's products include Oracle Database, MySQL, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud applications for enterprise resource planning, financial management, human resources, supply chain management, customer experience and industry-specific operations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.